Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

1.

Shortened interval between tetanus vaccines.

Lodolce AE.

Ann Pharmacother. 2012 Jun;46(6):884-8. doi: 10.1345/aph.1Q651. Epub 2012 Jun 5. Review.

PMID:
22669800
[PubMed - indexed for MEDLINE]
2.

Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.

America Academy of Pediatrics Commitee on Infectious Diseases.

Pediatrics. 2006 Mar;117(3):965-78. Epub 2005 Dec 28.

PMID:
16382131
[PubMed - indexed for MEDLINE]
3.

How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?

Halperin SA, Sweet L, Baxendale D, Neatby A, Rykers P, Smith B, Zelman M, Maus D, Lavigne P, Decker MD.

Pediatr Infect Dis J. 2006 Mar;25(3):195-200.

PMID:
16511379
[PubMed - indexed for MEDLINE]
4.

Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).

Broder KR, Cortese MM, Iskander JK, Kretsinger K, Slade BA, Brown KH, Mijalski CM, Tiwari T, Weston EJ, Cohn AC, Srivastava PU, Moran JS, Schwartz B, Murphy TV; Advisory Committee on Immunization Practices (ACIP).

MMWR Recomm Rep. 2006 Mar 24;55(RR-3):1-34.

PMID:
16557217
[PubMed - indexed for MEDLINE]
Free Article
5.

Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.

Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega-Sanchez I, Lee GM, Tiwari T, Cohn AC, Slade BA, Iskander JK, Mijalski CM, Brown KH, Murphy TV; Centers for Disease Control and Prevention; Advisory Committee on Immunization Practices; Healthcare Infection Control Practices Advisory Committee.

MMWR Recomm Rep. 2006 Dec 15;55(RR-17):1-37.

PMID:
17167397
[PubMed - indexed for MEDLINE]
Free Article
6.

Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).

Murphy TV, Slade BA, Broder KR, Kretsinger K, Tiwari T, Joyce PM, Iskander JK, Brown K, Moran JS; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2008 May 30;57(RR-4):1-51. Review. Erratum in: MMWR Morb Mortal Wkly Rep. 2008 Jul 4;57(26):723.

PMID:
18509304
[PubMed - indexed for MEDLINE]
Free Article
7.

Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix(®)): results of two randomized trials.

Weston WM, Friedland LR, Wu X, Howe B.

Vaccine. 2012 Feb 21;30(9):1721-8. doi: 10.1016/j.vaccine.2011.12.055. Epub 2011 Dec 31.

PMID:
22212127
[PubMed - indexed for MEDLINE]
8.

Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.

Zepp F, Knuf M, Habermehl P, Mannhardt-Laakmann W, Howe B, Friedland LR.

J Pediatr. 2006 Nov;149(5):603-610.

PMID:
17095328
[PubMed - indexed for MEDLINE]
9.
10.

Additional recommendations for use of tetanus toxoid, reduced-content diphtheria toxoid, and acellular pertussis vaccine (Tdap).

Centers for Disease Control and Prevention; American Academy of Pediatrics Committee on Infectious Diseases.

Pediatrics. 2011 Oct;128(4):809-12. doi: 10.1542/peds.2011-1752. Epub 2011 Sep 26.

PMID:
21949151
[PubMed - indexed for MEDLINE]
Free Article
11.

Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.

Knuf M, Habermehl P, Faber J, Bock HL, Sänger R, Bogaerts H, Clemens R, Schuind A, du Prel JB, Schmitt HJ.

Vaccine. 2006 Jul 7;24(27-28):5627-36. Epub 2006 May 2.

PMID:
16740348
[PubMed - indexed for MEDLINE]
12.

Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older - Advisory Committee on Immunization Practices (ACIP), 2012.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2012 Jun 29;61(25):468-70. Erratum in: MMWR Morb Mortal Wkly Rep. 2012 Jul 13;61(27):515.

PMID:
22739778
[PubMed - indexed for MEDLINE]
Free Article
13.
14.

New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel).

Johns TL, Hutter GE.

Ann Pharmacother. 2010 Mar;44(3):515-23. doi: 10.1345/aph.1M468. Review.

PMID:
20197476
[PubMed - indexed for MEDLINE]
15.

Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: a placebo-controlled trial.

Beytout J, Launay O, Guiso N, Fiquet A, Baudin M, Richard P, Baptiste C, Soubeyrand B.

Hum Vaccin. 2009 May;5(5):315-21. Epub 2009 May 1.

PMID:
19011374
[PubMed - indexed for MEDLINE]
Free Article
16.

A modified vaccine reduces the rate of large injection site reactions to the preschool booster dose of diphtheria-tetanus-acellular pertussis vaccine: results of a randomized, controlled trial.

Scheifele DW, Halperin SA, Ochnio JJ, Ferguson AC, Skowronski DM.

Pediatr Infect Dis J. 2005 Dec;24(12):1059-66. Erratum in: Pediatr Infect Dis J. 2006 Mar;25(3):229.

PMID:
16371866
[PubMed - indexed for MEDLINE]
17.

Adverse events after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2010.

Moro PL, Yue X, Lewis P, Haber P, Broder K.

Vaccine. 2011 Nov 21;29(50):9404-8. doi: 10.1016/j.vaccine.2011.05.100. Epub 2011 Sep 13.

PMID:
21920404
[PubMed - indexed for MEDLINE]
18.

Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults.

Halperin SA, Smith B, Russell M, Scheifele D, Mills E, Hasselback P, Pim C, Meekison W, Parker R, Lavigne P, Barreto L.

Pediatr Infect Dis J. 2000 Apr;19(4):276-83.

PMID:
10783014
[PubMed - indexed for MEDLINE]
19.

Tetanus and pertussis vaccination coverage among adults aged ≥ 18 years --- United States, 1999 and 2008.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2010 Oct 15;59(40):1302-6.

PMID:
20948508
[PubMed - indexed for MEDLINE]
Free Article
20.

Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines.

Rennels MB, Deloria MA, Pichichero ME, Losonsky GA, Englund JA, Meade BD, Anderson EL, Steinhoff MC, Edwards KM.

Pediatrics. 2000 Jan;105(1):e12.

PMID:
10617749
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk